Gajewski and colleagues elegantly described the role of cGAS-STING pathway activation in cancer, emphasizing how cancer outcomes are influenced by the successful priming of T cells by activated antigen-presenting cells in the tumour microenvironment. The gene discussed is STING1; the disease is cancer.